Acute Modafinil Effects on Attention and Inhibitory Control in Methamphetamine-Dependent Humans
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Individuals who are methamphetamine dependent exhibit higher rates of cognitive dysfunction than healthy people who do not use methamphetamine, and this dysfunction may have a negative effect on the success of behavioral treatments for the disorder. Therefore, a medication that improves cognition, such as modafinil (Provigil), may serve as a useful adjunct to behavioral treatments for methamphetamine dependence. Although cognitive-enhancing effects of modafinil have been reported in several populations, little is known about the effects of modafinil in methamphetamine-dependent individuals. We thus sought to evaluate the effects of modafinil on the cognitive performance of methamphetamine-dependent and healthy individuals. METHOD: Seventeen healthy subjects and 24 methamphetamine- dependent subjects participated in this randomized, double-blind, placebo-controlled, crossover study. Effects of modafinil (200 mg, single oral dose) were assessed on participants' performance on tests of inhibitory control, working memory, and processing speed/attention. RESULTS: Across subjects, modafinil improved performance on a test of sustained attention, with no significant improvement on any other cognitive tests. However, within the methamphetamine-dependent group only, participants with a high baseline frequency of methamphetamine use demonstrated a greater effect of modafinil on tests of inhibitory control and processing speed than those participants with low baseline use of methamphetamine. CONCLUSIONS: Although modafinil produced limited effects across all participants, methamphetamine-dependent participants with a high baseline use of methamphetamine demonstrated significant cognitive improvement on modafinil relative to those with low baseline methamphetamine use. These results add to the findings from a clinical trial that suggested that modafinil may be particularly useful in methamphetamine-dependent subjects who use the drug frequently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Testing the efficiency and independence of attentional networks
Fan, J., McCandliss, B. D., Sommer, T., Raz, A., & Posner, M. I. (2002) · Journal of Cognitive Neuroscience · doi:10.1162/089892902317361886 · Cited by 3,717 · cited 1×
“ATTENTION NETWORKS TASK (CNP TEST BATTERY, MODELED AFTER FAN ET AL., 2002): The Attention Networks Task is a computerized measure of inhibitory control.”
Fagerström, K.-O. (1978) · Addictive Behaviors · doi:10.1016/0306-4603(78)90024-2 · Cited by 2,221
Jentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · cited 1×
“In addition to IQ, evidence suggests that inhibitory control function may also be related to the ability of MAdependent individuals to resist drug-related compulsions when striving to maintain abstinence (Baler and Volkow, 2006; Jentsch and Taylor, 1999).”
BackgroundModafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713 · cited 2×
“The specifi c mechanism by which modafi nil produces these effects has not been identifi ed, but modafi nil increases extracellular levels of dopamine, norepinephrine, serotonin, glutamate, and histamine, and it decreases γ-aminobutyric acid levels (Minzenberg and Carter, 2008).”
BackgroundMethodDrug addiction: the neurobiology of disrupted self-control
Baler, R. D., & Volkow, N. D. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.005 · Cited by 640 · cited 2×
“In addition to IQ, evidence suggests that inhibitory control function may also be related to the ability of MAdependent individuals to resist drug-related compulsions when striving to maintain abstinence (Baler and Volkow, 2006; Jentsch and Taylor, 1999).”
BackgroundThe nature, time course and severity of methamphetamine withdrawal
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01160.x · Cited by 458 · cited 1×
“After intake, the MA participants relaxed on the hospital ward for 3 days and typically slept for signifi cant periods, consistent with the literature on the MA withdrawal syndrome (McGregor et al., 2005).”
ResultDeficits in response inhibition associated with chronic methamphetamine abuse
Monterosso, J. R., Aron, A. R., Cordova, X., Xu, J., & London, E. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.002 · Cited by 425
Self-citationModafinil for the treatment of cocaine dependence
Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235 · cited 1×
“Results from these trials have sometimes shown a positive effect of modafi nil on stimulant abstinence, but the results have been variable (see Anderson et al., 2009; Heinzerling et al., 2010; McGaugh et al., 2009; Shearer et al., 2009).”
ResultA double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159 · cited 1×
“Results from these trials have sometimes shown a positive effect of modafi nil on stimulant abstinence, but the results have been variable (see Anderson et al., 2009; Heinzerling et al., 2010; McGaugh et al., 2009; Shearer et al., 2009).”
ResultA Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104910.75206.b9 · Cited by 144 · cited 2×
“…working memory, have also been noted in some psychiatric groups, such as individuals with schizophrenia (Rosenthal and Bryant, 2004; Turner et al., 2004b), major depression (DeBattista et al., 2004), and attention-defi cit/hyperactivity disorder (ADHD; Greenhill et al., 2006; Turner et al., 2004a).”
BackgroundSimon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117 · cited 2×
“INDIVIDUALS WHO ARE DEPENDENT ON methamphetamine (MA) exhibit higher rates of cognitive dysfunction than healthy control participants in several domains, including sustained attention, episodic memory, information processing, inhibitory control, and executive functions (Monterosso et al., 2005; Nordahl et al., 2003; S…”
BackgroundHeinzerling, K. G., Swanson, A.-N., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.023 · Cited by 105 · cited 4×
“…and healthy subject samples (Hester et al., 2010; Müller et al., 2004; Turner et al., 2003, 2004a, 2004b; Walsh et al., 2004), higher doses (e.g., 400 mg) have been shown to be safe in MA-dependent participants (Heinzerling et al., 2010) and may produce a more pronounced cognitive effect.”
BackgroundResultInfluentialMcGregor, C., Srisurapanont, M., Mitchell, A., Wickes, W., & White, J. M. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.003 · Cited by 82 · cited 1×
“Indeed, evidence has suggested that modafi nil can curtail the effects of MA withdrawal symptoms in early abstinence, including reduced fatigue, irritability, and craving (McGregor et al., 2008).”
BackgroundKalechstein, A. D., De La Garza, II, & Newton, T. F. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00052.x · Cited by 67 · cited 5×
“…previous research has indicated that individuals with low IQ or low baseline performance are the most likely to show cognitive benefi ts with modafi nil (Kalechstein et al., 2010; Randall et al., 2005a), we did not fi nd signifi cant interactions between estimated IQ and response to modafi nil.”
BackgroundMethodInfluentialHester, R., Lee, N., Pennay, A., Nielsen, S., & Ferris, J. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021791 · Cited by 42 · cited 3×
“…study, immediate verbal memory was improved in MA-dependent participants receiving modafi nil (200 mg; n = 7) relative to those receiving placebo (n = 7) (Hester et al., 2010), but differences between the groups were not observed on measures of visual memory, processing speed, or verbal fl uency.”
Background
Cited by
Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis.
Smith, J. L., Mattick, R. P., Jamadar, S. D., & Iredale, J. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.009 · Cited by 546
Cognitive enhancement as a treatment for drug addictions
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.021 · Cited by 298
Acute effects of modafinil on brain resting state networks in young healthy subjects
Esposito, R., Cilli, F., Pieramico, V., Ferretti, A., Macchia, A., Tommasi, M., Saggino, A., Ciavardelli, D., Manna, A., Navarra, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069224 · Cited by 66
Addiction, cognitive decline and therapy: Seeking ways to escape a vicious cycle
Perry, C. J., & Lawrence, A. J. (2017) · Genes, Brain and Behavior · doi:10.1111/gbb.12325 · Cited by 60
Härtel-Petri, R., Krampe-Scheidler, A., Braunwarth, W.-D., Havemann-Reinecke, U., Jeschke, P., Looser, W., Mühlig, S., Schäfer, I., Scherbaum, N., Bothe, L., et al. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-105500 · Cited by 39
Metadata
- Authors
- Dean, A. C., Sevak, R. J., Monterosso, J. R., Hellemann, G., Sugar, C. A., & London, E. D.
- Venue
- Journal of Studies on Alcohol and Drugs
- Publisher
- Alcohol Research Documentation, Inc.
- Published
- 2011-11
- Volume
- 72
- Issue
- 6
- Pages
- 943-953
- ISSN
- 1937-1888 (ISSN-L)
- 1938-4114
- OpenAlex
- W1991257812
- Cited by
- 79
- References
- 15
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.